Immuron announces research collaboration By Investing.com
Immuron Ltd (NASDAQ:IMRN), an Australian biopharmaceutical company with a market capitalization of $12 million, disclosed a new research collaboration with...
Immuron Ltd (NASDAQ:IMRN), an Australian biopharmaceutical company with a market capitalization of $12 million, disclosed a new research collaboration with...
Highlights: New Research Collaboration with Monash University One proposal will target Antimicrobial Resistant Pathways to develop broad spectrum therapeutic drug...